What is the total investment amount and primary goal of the Eli Lilly–Resilience manufacturing expansion announced in the news?

Eli Lilly and Resilience will invest $750 million to expand pharmaceutical manufacturing capacity in the U.S. and strengthen the domestic medicine supply chain.

How many new jobs will be created by this expansion, and where?

The investment will create 400 new high-skilled jobs in the Cincinnati, Ohio region.

Eli Lilly, Resilience to Invest $750 Million in US Drug Manufacturing Expansion

Jul 30, 2026

Eli Lilly and Resilience plan to invest $750 million to expand U.S. pharmaceutical manufacturing capacity, strengthening the domestic medicine supply chain and creating 400 jobs. The partnership will boost production of critical medicines, including treatments for diabetes and obesity.

reuters

2026-01-13

Jan. 13 Business Watch: Plants Close in Brazil and the UK; Lilly to Pay $1.2 Billion for Ventyx

2026-04-17

Lilly's obesity pill Foundayo gets 1,390 prescriptions in debut week

2026-04-19

Eli Lilly in advanced talks to acquire Kelonia Therapeutics for over $2 billion, WSJ says

2026-04-24

Eli Lilly's Obesity Pill Records Modest Second Week as Battle with Novo Nordisk Intensifies

2026-04-30

S&P 500, Nasdaq On Course for Best Month Since 2020 Despite Middle East Risks